MFDS Holds First Meeting of Consortium to Support Commercialization of Domestically Developed Vaccines

On the 4th, the Ministry of Food and Drug Safety announced that it will hold the first meeting of the 'Vaccine Clinical Support Council (Council)' to assist in the commercialization of domestically developed vaccines.

Eleven companies developing vaccines such as tetanus, diphtheria, pertussis vaccines, and human papillomavirus vaccines (for cervical cancer prevention) in Korea will attend.

The main agenda of this meeting includes sharing the promotion plan of the Council and the 'Vaccine Completion Project,' which provides customized regulatory services for each product from research and development, clinical trials, commercialization, to export. The Vaccine Completion Project started in July to support the domestic development of essential national vaccination vaccines that have been dependent on imports.

Within the Council, for products with high import dependency that are being developed domestically, and vaccines that are the first to develop platforms in Korea, examiners will provide technical support to developers on non-clinical, quality, and clinical design at each clinical stage by product.

Photo related to vaccines

This content was produced with the assistance of AI translation services.